See more : Ensurge Micropower ASA (ENMPF) Income Statement Analysis – Financial Results
Complete financial analysis of Shilpa Medicare Limited (SHILPAMED.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shilpa Medicare Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Samsonite International S.A. (1910.HK) Income Statement Analysis – Financial Results
- Taboola.com, Ltd. (TBLAW) Income Statement Analysis – Financial Results
- Belysse Group NV (BELYS.BR) Income Statement Analysis – Financial Results
- MRC Global Inc. (MRC) Income Statement Analysis – Financial Results
- SÜSS MicroTec SE (SMHN.DE) Income Statement Analysis – Financial Results
Shilpa Medicare Limited (SHILPAMED.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.vbshilpa.com
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (APIs), intermediates, and formulations in India, the United States, Europe, and internationally. It's primary oncology and non-oncology APIs include capecitabine, gemcitabine hydrochloride, pemetrexed, axitinib, erlotinib hydrochloride, and irinotecan hydrochloride, as well as ambroxol, tranexmic acid, and ursodeoxycholic acid; and new drug delivery systems, peptides/biotech products, and specialty chemicals, etc. The company provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. In addition, It is involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.51B | 10.43B | 11.40B | 9.00B | 8.99B | 6.89B | 7.49B | 7.30B | 6.38B | 5.84B | 5.48B | 3.71B | 3.18B | 2.90B | 2.65B | 1.66B | 958.13M |
| Cost of Revenue | 4.08B | 4.17B | 3.84B | 2.71B | 2.78B | 2.57B | 3.56B | 3.72B | 3.70B | 3.25B | 3.14B | 2.15B | 1.84B | 1.64B | 1.48B | 1.01B | 696.05M |
| Gross Profit | 7.43B | 6.27B | 7.56B | 6.29B | 6.21B | 4.32B | 3.93B | 3.58B | 2.68B | 2.58B | 2.34B | 1.56B | 1.34B | 1.26B | 1.17B | 652.74M | 262.08M |
| Gross Profit Ratio | 64.59% | 60.05% | 66.31% | 69.92% | 69.10% | 62.69% | 52.47% | 49.06% | 41.98% | 44.25% | 42.63% | 42.13% | 42.18% | 43.48% | 43.99% | 39.22% | 27.35% |
| Research & Development | 309.56M | 491.02M | 550.61M | 338.09M | 368.99M | 213.04M | 272.77M | 240.77M | 213.40M | 159.02M | 95.22M | 45.90M | 23.57M | 12.52M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 218.35M | 295.29M | 552.27M | 357.21M | 541.80M | 151.88M | 102.63M | 85.49M | 79.93M | 52.53M | 43.88M | 22.79M | 19.89M | 13.70M | 86.08M | 71.06M | 27.42M |
| Selling & Marketing | 28.68M | 26.23M | 56.59M | 119.23M | 64.24M | 46.38M | 26.87M | 22.39M | 39.50M | 33.49M | 47.57M | 23.69M | 15.13M | 19.09M | 6.14M | 4.47M | 2.55M |
| SG&A | 247.04M | 321.52M | 608.86M | 476.44M | 606.04M | 198.27M | 129.50M | 107.88M | 119.43M | 86.02M | 91.45M | 46.48M | 35.02M | 32.78M | 92.22M | 75.52M | 29.97M |
| Other Expenses | 6.88B | 140.64M | 107.68M | 124.72M | 26.04M | 41.19M | 28.28M | 42.89M | 20.08M | 7.61M | 23.65M | 22.56M | 10.90M | 2.01M | 41.79M | -102.73M | 0.00 |
| Operating Expenses | 7.43B | 6.32B | 6.30B | 5.10B | 4.49B | 3.15B | 2.78B | 2.23B | 1.29B | 1.53B | 1.35B | 1.03B | 840.89M | 679.92M | 531.28M | 426.29M | 111.20M |
| Cost & Expenses | 10.05B | 10.49B | 10.14B | 7.81B | 7.26B | 5.72B | 6.34B | 5.95B | 4.99B | 4.78B | 4.49B | 3.17B | 2.68B | 2.32B | 2.02B | 1.44B | 807.25M |
| Interest Income | 13.84M | 17.70M | 20.67M | 34.38M | 14.96M | 56.52M | 35.05M | 29.00M | 31.80M | 17.20M | 13.97M | 3.81M | 63.79M | 33.46M | 17.75M | 10.36M | 25.20M |
| Interest Expense | 918.09M | 562.79M | 409.34M | 217.07M | 45.58M | 32.19M | 22.41M | 28.81M | 39.33M | 40.50M | 35.24M | 14.39M | 16.74M | 20.58M | 54.23M | 57.67M | 8.52M |
| Depreciation & Amortization | 1.08B | 954.99M | 798.02M | 539.77M | 437.77M | 420.62M | 372.22M | 306.45M | 231.39M | 214.12M | 232.18M | 153.40M | 143.62M | 129.57M | 127.16M | 94.11M | 35.11M |
| EBITDA | 2.44B | 1.20B | 2.27B | 2.73B | 2.37B | 1.89B | 1.83B | 1.87B | 1.68B | 1.33B | 1.22B | 737.75M | 693.75M | 789.64M | 763.53M | 321.37M | 185.99M |
| EBITDA Ratio | 21.25% | 10.93% | 19.41% | 21.91% | 25.08% | 23.51% | 21.86% | 24.40% | 25.72% | 22.84% | 22.31% | 20.00% | 21.68% | 26.86% | 28.82% | 19.31% | 19.41% |
| Operating Income | 1.37B | -96.54M | 1.17B | 1.21B | 1.70B | 1.03B | 979.59M | 1.36B | 1.38B | 1.12B | 990.98M | 589.37M | 546.34M | 650.06M | 636.37M | 227.26M | 150.88M |
| Operating Income Ratio | 11.87% | -0.93% | 10.28% | 13.42% | 18.86% | 15.02% | 13.08% | 18.59% | 21.70% | 19.18% | 18.08% | 15.87% | 17.17% | 22.39% | 24.02% | 13.65% | 15.75% |
| Total Other Income/Expenses | -822.87M | -286.25M | -235.66M | 774.83M | 154.11M | 190.68M | 217.53M | 112.25M | 17.68M | -41.30M | -36.46M | -19.41M | -12.96M | -10.58M | 2.93M | -150.85M | 16.89M |
| Income Before Tax | 543.41M | -382.80M | 1.02B | 1.95B | 1.88B | 1.36B | 1.37B | 1.46B | 1.40B | 1.08B | 954.52M | 569.96M | 533.38M | 639.48M | 636.94M | 75.60M | 167.56M |
| Income Before Tax Ratio | 4.72% | -3.67% | 8.97% | 21.67% | 20.92% | 19.69% | 18.26% | 20.07% | 22.02% | 18.47% | 17.41% | 15.35% | 16.76% | 22.03% | 24.04% | 4.54% | 17.49% |
| Income Tax Expense | 223.86M | -73.64M | 416.83M | 488.48M | 334.92M | 261.77M | 339.06M | 420.39M | 356.19M | 352.16M | 203.03M | 95.31M | 122.24M | 146.00M | 210.99M | 86.03M | 54.36M |
| Net Income | 318.74M | -324.76M | 606.62M | 1.48B | 1.56B | 1.12B | 1.05B | 1.08B | 1.08B | 736.91M | 756.69M | 473.42M | 412.38M | 493.49M | 425.95M | -10.42M | 113.20M |
| Net Income Ratio | 2.77% | -3.11% | 5.32% | 16.42% | 17.37% | 16.29% | 14.05% | 14.74% | 16.99% | 12.62% | 13.80% | 12.75% | 12.96% | 17.00% | 16.08% | -0.63% | 11.81% |
| EPS | 3.67 | -3.74 | 6.99 | 18.13 | 19.15 | 13.77 | 13.07 | 13.81 | 13.59 | 9.60 | 10.68 | 6.44 | 5.72 | 7.16 | 6.45 | -0.16 | 1.77 |
| EPS Diluted | 3.67 | -3.74 | 6.99 | 18.13 | 19.15 | 13.77 | 13.07 | 13.81 | 13.59 | 9.60 | 10.19 | 6.44 | 5.72 | 7.08 | 6.45 | -0.16 | 1.77 |
| Weighted Avg Shares Out | 86.85M | 86.80M | 86.80M | 81.53M | 81.53M | 81.53M | 80.53M | 77.90M | 77.10M | 76.78M | 73.57M | 73.57M | 72.11M | 69.18M | 66.07M | 65.52M | 63.82M |
| Weighted Avg Shares Out (Dil) | 86.85M | 86.80M | 86.80M | 81.53M | 81.53M | 81.53M | 80.53M | 77.90M | 77.90M | 76.78M | 77.10M | 73.57M | 72.11M | 69.96M | 66.07M | 65.52M | 63.82M |
Source: https://incomestatements.info
Category: Stock Reports